KIBRAgene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

KIBRAgene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia

Published:2012-03 Issue:3 Volume:7 Page:211-215
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Shinawi Thoraia,Hill Victoria,Dagklis Antonis,Baliakas Panagiotis,Stamatopoulos Kostas,Agathanggelou Angleo,Stankovic Tanja,Maher Eamonn R.,Ghia Paolo,Latif Farida

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/epi.7.3.19222

Reference30 articles.

1. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?;Caligaris-Cappio;J Clin Oncol,2008

2. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia;Damle;Blood,1999

3. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia;Hamblin;Blood,1999

4. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression;Ghia;Blood,2003

5. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia;Crespo;N Engl J Med,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrative pan-cancer analysis of WWC family genes and functional validation in lung cancer;Cellular Signalling;2024-03

2. The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review;Advances in Hematology;2024-01

3. KIBRA connects Hippo signaling and cancer;Experimental Cell Research;2021-06

4. WWC Proteins: Important Regulators of Hippo Signaling in Cancer;Cancers;2021-01-15

5. Low expression of WWC1 , a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome;FEBS Open Bio;2019-06